| pubmed-article:21591943 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21591943 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
| pubmed-article:21591943 | lifeskim:mentions | umls-concept:C0383429 | lld:lifeskim |
| pubmed-article:21591943 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:21591943 | pubmed:issue | 20 | lld:pubmed |
| pubmed-article:21591943 | pubmed:dateCreated | 2011-5-19 | lld:pubmed |
| pubmed-article:21591943 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:abstractText | There are few comparisons of antibody induction therapy allowing early glucocorticoid withdrawal in renal-transplant recipients. The purpose of the present study was to compare induction therapy involving alemtuzumab with the most commonly used induction regimens in patient populations at either high immunologic risk or low immunologic risk. | lld:pubmed |
| pubmed-article:21591943 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21591943 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21591943 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21591943 | pubmed:month | May | lld:pubmed |
| pubmed-article:21591943 | pubmed:issn | 1533-4406 | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:FirstM RoyMR | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:HanawayMichae... | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:WoodleE... | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:KaufmanDixon... | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:HolmanJohnJ | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:PeddiV RamVR | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:MulgaonkarSha... | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:CroyRichardR | lld:pubmed |
| pubmed-article:21591943 | pubmed:author | pubmed-author:INTAC Study... | lld:pubmed |
| pubmed-article:21591943 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21591943 | pubmed:day | 19 | lld:pubmed |
| pubmed-article:21591943 | pubmed:volume | 364 | lld:pubmed |
| pubmed-article:21591943 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21591943 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21591943 | pubmed:pagination | 1909-19 | lld:pubmed |
| pubmed-article:21591943 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:meshHeading | pubmed-meshheading:21591943... | lld:pubmed |
| pubmed-article:21591943 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21591943 | pubmed:articleTitle | Alemtuzumab induction in renal transplantation. | lld:pubmed |
| pubmed-article:21591943 | pubmed:affiliation | University of Alabama at Birmingham, Birmingham, USA. michael.hanaway@ccc.uab.edu | lld:pubmed |
| pubmed-article:21591943 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21591943 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:21591943 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21591943 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21591943 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21591943 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21591943 | lld:pubmed |
